Ankunda Ivan

life

[Prof Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @EADirectorDNDi]

Over one billion people suffer from neglected tropical diseases (NTDs), causing immense suffering & disability. It doesn’t have to be this way.

This #WorldNTDDay, let’s raise our voices and take action to #EndTheNeglect. Together, we can #BeatNTDs for good.

[The END Fund @TheENDFund]

Visceral leishmaniasis, the "silent killer" is deadly in more than 90% of cases when untreated. Read about the effort to curb a surge in cases in Turkana, Kenya. https://t.co/BI0xSOa8E3

[Drugs for Neglected Diseases initiative @DNDi]

The latest Leishmaniasis East Africa Platform (LEAP) Newsletter is out! The 9th issue dives into Africa's efforts to eliminate visceral leishmaniasis, community-driven advocacy, and the successful launch of the Visceral Leishmaniasis Strategic Framework.📰 https://t.co/drCKFbKGQm

[Drugs for Neglected Diseases initiative @DNDi]

Visceral #leishmaniasis is deadly if untreated. In Eastern Africa, half of those affected are children under 15. Current treatments are painful and potentially toxic.
@RFI featured our work to change this.
🎙️Listen/read here [in French]: https://t.co/Kf2vMpwXg3

[Prof Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @EADirectorDNDi]

Skin #NTDs pose a significant public health challenge globally, with the highest burden in sub-Saharan Africa.

@WHO’s 2024 Global Report on NTDs notes an increase in the adoption & execution of integrated strategies targeting skin NTDs. Read more in @PLOS https://t.co/3eWOiwL8Qd

[The END Fund @TheENDFund]

World NTD Day (January 30th, next Tuesday!) is a key moment to highlight the commitment to ending NTDs, build political will and secure increased resources. Check out how you can help support these effort! https://t.co/glwdvyuclo

[Prof Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @EADirectorDNDi]

'Laborious procurement processes, supply chain hurdles & limited funding are some of the obstacles that continue to challenge access to treatment for neglected patients. @DNDi is bridging treatment gaps by developing & facilitating access initiatives for #NTDs.' says @BoloSimon

[Prof Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @EADirectorDNDi]

'The most significant barrier is access to treatment especially for #leishmaniasis patients. The disease burden in most affected regions is still unclear considering most patients suffer in silence.
Investing in R&D is crucial to tackle elimination.' @den_margriet from @MSF

[Prof Sam Kariuki, BVM, MSc, PhD, DSc (Hons, LSTM) @EADirectorDNDi]

#Climatechange continues to exacerbate the spread of vectors for some #NTDs. Dengue fever has in the recent past reemerged due to these challenges.

Researchers need to expand surveillance activities to be able to advise policy makers in the elimination efforts. #beatNTDs

[Drugs for Neglected Diseases initiative @DNDi]

In 20 years, we’ve delivered 13 new treatments for 6 deadly diseases, saving millions of lives.

Find out how our partnerships and innovative way of doing R&D have led us here ⤵️ https://t.co/aFyQE8mI8r

[The END Fund @TheENDFund]

Climate change impacts where vectors that spread neglected tropical diseases live. We must invest in NTDs so we can monitor their emergence, adapt in real-time and, respond nimbly to ensure people are able to live healthy and prosperous lives. #COP28 #RLMForum2023

[The END Fund @TheENDFund]

As the effort to #BeatNTDs aligns more with the SDGs, issues like the impact of climate change on NTDs is beginning to be explored. While the investigation into the threat continues, we know that changing patterns like flooding and drought will have an impact on #NTDs.

[Ankunda Ivan @AnkundaIvan]

Performance review meeting in karamoja region, Uganda on Active surveillance of Visceral leishmaniasis organized by MOH with support from the END FUND